Key statistics
On Thursday, Contineum Therapeutics Inc (CTNM:NSQ) closed at 20.08, -8.73% below its 52-week high of 22.00, set on Jul 01, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 19.10 |
---|---|
High | 20.17 |
Low | 18.72 |
Bid | 19.20 |
Offer | 21.18 |
Previous close | 18.49 |
Average volume | 37.58k |
---|---|
Shares outstanding | 25.72m |
Free float | 16.86m |
P/E (TTM) | -- |
Market cap | 475.62m USD |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
- Contineum Therapeutics to Present at Multiple Upcoming Investor Conferences
- Contineum Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
- Contineum Therapeutics Announces Publication of Encouraging Data in the Proceedings of the National Academy of Sciences on PIPE-307, Its M1 Receptor Selective Inhibitor, in Clinical Development for Relapse-Remitting Multiple Sclerosis
- Contineum Therapeutics Announces Appointment of Sarah Boyce to Board of Directors